Gain Therapeutics CEO to join ROTH healthcare conference panel on Sept. 29
AI Summary- Gain Therapeutics said Gene Mack will participate in a ROTH conference panel and investor meetings.
- September 29, 2026, is the conference date; Mack’s presentation begins at 11:00 a.m. ET.
- Rexaceract is in a Phase 1b Parkinson’s disease trial involving patients with or without GBA1 mutations.